Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.
Document Type
Article
Publication Date
6-13-2019
Institution/Department
Maine Medical Center Research Center
Journal Title
The New England journal of medicine
MeSH Headings
Canagliflozin, Diabetes Mellitus, Type 2, Humans, Kidney, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors
ISSN
1533-4406
First Page
2371
Last Page
2373
Recommended Citation
Ingelfinger, Julie R and Rosen, Clifford J, "Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease." (2019). Maine Medical Center. 1371.
https://knowledgeconnection.mainehealth.org/mmc/1371
COinS
